O Centro Hospitalar Universitário de São João é um hospital universitário da cidade do Porto, com uma forte ligação à Faculdade de Medicina da Universidade do Porto.

During the past decade, Centro Hospitalar de São João, EPE conducted 119 clinical trials. In the 10-year time frame, 119 clinical trials started and 41 clinical trials were completed, i.e. on average, 34.5% percent of trials that started reached the finish line to date. In the past 5 years, 63 clinical trials started and 30 clinical trials were completed. i.e. 47.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Hospitalar de São João, EPE" #1 sponsor was "Boehringer Ingelheim" with 20 trials, followed by "Universidade do Porto" with 10 trials sponsored, "Takeda" with 8 trials sponsored, "Bayer" with 6 trials sponsored and "Celgene" with 6 trials sponsored. Other sponsors include 78 different institutions and companies that sponsored additional 61 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Hospitalar de São João, EPE" #1 collaborator was "Centro Hospitalar De São João, E.P.E." with 4 trials as a collaborator, "Eli Lilly and Company" with 4 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Andalusian Network for Design and Translation of Advanced Therapies" with 2 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include 82 different institutions and companies that were collaborators in the rest 90 trials.

According to Clinical.Site data, the most researched conditions in "Centro Hospitalar de São João, EPE" are "Ulcerative Colitis" (6 trials), "Heart Failure" (5 trials), "Crohn Disease" (4 trials), "Multiple Myeloma" (4 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "Centro Hospitalar de São João, EPE" in a lesser frequency.

Most popular intervention types in "Centro Hospitalar de São João, EPE" are "Drug" (89 trials), "Other" (17 trials), "Biological" (9 trials), "Device" (7 trials) and "Behavioral" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (48 trials), "Cisplatin" (4 trials), "Etrasimod" (4 trials), "Filgotinib" (4 trials) and "Botulinum toxin type A" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centro Hospitalar de São João, EPE" are 125 trials for "All" genders, 7 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 63 active trials in "Centro Hospitalar de São João, EPE". 2 are not yet recruiting, 36 are recruiting, 24 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 56 completed trials in Centro Hospitalar de São João, EPE, undefined suspended trials, and 10 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Hospitalar de São João, EPE, 1 "Phase 1" clinical trials were conducted, 21 "Phase 2" clinical trials and 68 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 11 trials that are defined as “Not Applicable".